Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary objectives of this study are to evaluate the efficacy of remdesivir (RDV) in reducing the rate of of coronavirus disease 2019 (COVID-19) related hospitalization or all-cause death in non-hospitalized participants with early stage COVID-19 and to evaluate the safety of RDV administered in an outpatient setting.
Epistemonikos ID: 2854e35fd73d3ea851fab89e3fd5981579d07953
First added on: Aug 07, 2020